{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:39:56Z","timestamp":1793173196171,"version":"4.5.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T00:00:00Z","timestamp":1514505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Unions Seventh Programme","award":["316940"],"award-info":[{"award-number":["316940"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0189100","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T13:25:38Z","timestamp":1514553938000},"page":"e0189100","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi"],"prefix":"10.1371","volume":"12","author":[{"given":"M.","family":"Arcuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Di Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. F.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Saul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A.","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8243-3181","authenticated-orcid":true,"given":"F.","family":"Micoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,12,29]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2214-109X(14)70301-8","article-title":"Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment","volume":"2","author":"V Mogasale","year":"2014","journal-title":"Lancet Glob Health"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fimmu.2014.00012","article-title":"Designing vaccines for the twenty-first century society","volume":"5","author":"O Finco","year":"2014","journal-title":"Front Immunol"},{"key":"ref3"},{"issue":"Suppl 1","key":"ref4","first-page":"5","article-title":"Comparative tolerability and immunogenicity of Typherix or Typhim Vi in healthy adults: 0, 12-month and 0, 24-month administration","volume":"15","author":"E Lebacq","year":"2001","journal-title":"BioDrugs"},{"key":"ref5","unstructured":"WHO. WHO Technical Report Series No.987. World Health Organization. 2014."},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1586\/14760584.2013.845529","article-title":"Development of Vi conjugate\u2014a new generation of typhoid vaccine","volume":"12","author":"SC Szu","year":"2013","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4161\/hv.29054","article-title":"Vaccines against invasive Salmonella disease: current status and future directions","volume":"10","author":"CA MacLennan","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1517\/17460441.2011.609554","article-title":"The design of semi-synthetic and synthetic glycoconjugate vaccines","volume":"6","author":"P Costantino","year":"2011","journal-title":"Expert Opin Drug Discov"},{"key":"ref9","first-page":"153","article-title":"Preparation of polysaccharide-conjugate vaccines","volume":"87","author":"CC Peeters","year":"2003","journal-title":"Methods Mol Med"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.vaccine.2010.11.022","article-title":"Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi","volume":"29","author":"F Micoli","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/CVI.00387-10","article-title":"Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar Typhi","volume":"18","author":"S Rondini","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"e25398","DOI":"10.1371\/journal.pone.0025398","article-title":"Safety, immunogenicity and dose ranging of a new Vi-CRM(1)(9)(7) conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults","volume":"6","author":"P van Damme","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials","volume":"14","author":"ZA Bhutta","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"ref14","first-page":"SC01","article-title":"A Study on Longevity of Immune Response after Vaccination with Salmonella Typhi Vi Conjugate Vaccine (Pedatyph) in Children","volume":"9","author":"B Chinnasami","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"44","key":"ref15","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.1016\/j.vaccine.2011.08.019","article-title":"Physico-chemical properties of Salmonella typhi Vi polysaccharide-diphtheria toxoid conjugate vaccines affect immunogenicity","volume":"29","author":"SJ An","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/CVI.00266-09","article-title":"Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates","volume":"17","author":"C Cui","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/IAI.67.11.5806-5810.1999","article-title":"Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam","volume":"67","author":"Z Kossaczka","year":"1999","journal-title":"Infect Immun"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/IAI.57.12.3823-3827.1989","article-title":"Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi","volume":"57","author":"SC Szu","year":"1989","journal-title":"Infect Immun"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1128\/IAI.59.12.4555-4561.1991","article-title":"Relation between structure and immunologic properties of the Vi capsular polysaccharide","volume":"59","author":"SC Szu","year":"1991","journal-title":"Infect Immun"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1084\/jem.166.5.1510","article-title":"Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals","volume":"166","author":"SC Szu","year":"1987","journal-title":"J Exp Med"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.vaccine.2011.11.108","article-title":"Production of a conjugate vaccine for Salmonella enterica serovar Typhi from Citrobacter Vi","volume":"30","author":"F Micoli","year":"2012","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jpba.2017.02.042","article-title":"Determination of free polysaccharide in Vi glycoconjugate vaccine against typhoid fever","volume":"139","author":"C Giannelli","year":"2017","journal-title":"Journal of pharmaceutical and biomedical analysis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijbiomac.2013.06.014","article-title":"Comparison of EDC and DMTMM efficiency in glycoconjugate preparation","volume":"60","author":"P Farkas","year":"2013","journal-title":"Int J Biol Macromol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.carbpol.2014.02.070","article-title":"A systematic analysis of DMTMM vs EDC\/NHS for ligation of amines to hyaluronan in water","volume":"108","author":"M D'Este","year":"2014","journal-title":"Carbohydr Polym"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1128\/IAI.66.5.2186-2192.1998","article-title":"Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy","volume":"66","author":"MR Wessels","year":"1998","journal-title":"Infect Immun"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1590\/S0001-37652005000200009","article-title":"Vaccines based on the cell surface carbohydrates of pathogenic bacteria","volume":"77","author":"C Jones","year":"2005","journal-title":"An Acad Bras Cienc"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biologicals.2011.05.004","article-title":"Biochemical and biological characteristics of cross-reacting material 197 CRM197, a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications","volume":"39","author":"M Broker","year":"2011","journal-title":"Biologicals"},{"issue":"Pt 7","key":"ref28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1099\/jmm.0.05378-0","article-title":"Protection in a mouse peritonitis model mediated by iron-regulated outer-membrane protein of Salmonella typhi coupled to its Vi antigen","volume":"53","author":"S Chibber","year":"2004","journal-title":"J Med Microbiol"},{"issue":"20","key":"ref29","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1016\/j.vaccine.2006.03.002","article-title":"Evaluation of a novel Vi conjugate vaccine in a murine model of salmonellosis","volume":"24","author":"C Hale","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"ref30","first-page":"268","article-title":"[Conjugate vaccines against bacterial infections: typhoid fever]","volume":"34","author":"J Paniagua","year":"1992","journal-title":"Salud Publica Mex"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1128\/IAI.62.12.5545-5549.1994","article-title":"Synthesis and some immunologic properties of an O-acetyl pectin [poly(1\u2014>4)-alpha-D-GalpA]-protein conjugate as a vaccine for typhoid fever","volume":"62","author":"SC Szu","year":"1994","journal-title":"Infect Immun"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/IAI.37.1.15-22.1982","article-title":"Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates","volume":"37","author":"EC Beuvery","year":"1982","journal-title":"Infect Immun"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4161\/hv.1.4.2018","article-title":"Group C meningococcal polysaccharide-tetanus toxoid conjugate vaccine: a meta-analysis of immunogenicity, safety and posology","volume":"1","author":"EM Pollabauer","year":"2005","journal-title":"Hum Vaccin"},{"issue":"12","key":"ref34","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.4049\/jimmunol.146.12.4308","article-title":"A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice","volume":"146","author":"CC Peeters","year":"1991","journal-title":"J Immunol"},{"issue":"1\u20136","key":"ref35","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1699-0463.1998.tb01380.x","article-title":"The effect of conjugation on immunogenicity and potency of protein carriers of polyribosylribitol phosphate (PRP) conjugated vaccines in the mouse model","volume":"106","author":"H Shams","year":"1998","journal-title":"APMIS"},{"issue":"11","key":"ref36","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.vaccine.2015.01.046","article-title":"Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines","volume":"33","author":"K Lockyer","year":"2015","journal-title":"Vaccine"},{"issue":"45","key":"ref37","doi-asserted-by":"crossref","first-page":"13198","DOI":"10.1002\/anie.201506112","article-title":"Sugar-Protein Connectivity Impacts on the Immunogenicity of Site-Selective Salmonella O-Antigen Glycoconjugate Vaccines","volume":"54","author":"G Stefanetti","year":"2015","journal-title":"Angew Chem Int Ed Engl"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/CVI.00532-10","article-title":"The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines","volume":"18","author":"VD Thiem","year":"2011","journal-title":"Clinical and vaccine immunology: CVI"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.4049\/jimmunol.1103166","article-title":"The capsular polysaccharide Vi from Salmonella typhi is a B1b antigen","volume":"189","author":"JL Marshall","year":"2012","journal-title":"Journal of immunology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0189100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T04:52:20Z","timestamp":1693371140000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0189100"}},"subtitle":[],"editor":[{"given":"Nicholas J.","family":"Mantis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,29]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0189100","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,29]]}}}